Liver cirrhosis is a known risk factor for postoperative mortality in patients undergoing cardiac surgery. Clinical assessment of liver cirrhosis using the widely accepted Child-Pugh (CP) score is thus vital for evaluation of surgical options and perioperative care. However, detailed mortality rates as a consequence of liver cirrhosis are unclear. This review aimed to stratify the risk of short-term (<30 days) and overall (up to 10 years) mortality after cardiac surgery in patients with liver cirrhosis, classified by the CP score. Thus, PubMed, Embase, CINAHL and the Cochrane Library were systematically reviewed by two independent investigators for studies published up to February 2014, in which mortality in cirrhotic patients, classified by the CP classification, undergoing cardiac surgery was evaluated postoperatively. A total of 993 articles were identified. After critical appraisal of 21 articles, 19 were selected for final analysis. Weighted short-term mortality of cirrhotic patients undergoing cardiac surgery was 19.3% [95% confidence interval (CI): 16.4-22.5%]. Across the different CP groups, shortterm mortality appeared to be 9.0% (95% CI: 6.6-12.2%), 37.7% (95% CI: 30.8-44.3%) and 52.0% (95% CI: 33.5-70.0%) in Groups A, B and C, respectively. Weighted overall mortality within 1 year was 42.0% (95% CI: 36.0-48.3%) in all cirrhotic patients. Subdivided in groups, overall mortality within that 1 year was 27.2% (95% CI: 20.9-34.7%), 66.2% (95% CI: 54.3-76.3%) and 78.9% (95% CI: 56.1-92.1%) in Groups A, B and C, respectively. In conclusion, short-term mortality is considerably increased in patients with liver cirrhosis CP class B and C. Overall mortality is significantly high in all classes of liver cirrhosis.
INTRODUCTION
Cardiac surgery is among the most frequently performed surgical procedures, with over 2 million operations performed worldwide each year [1] . Significant improvements in outcomes have been achieved over the last decades, yet particularly in high-risk patients cardiac surgery still carries a risk of complications. Liver cirrhosis is among a number of concomitant diseases, which are associated with a high risk when undergoing cardiac surgery [2] . The prevalence of liver cirrhosis in patients undergoing cardiac surgery is reported to be 0.2-0.3%, accounting for over 6000 cases worldwide yearly [3] .
Due to a compromised health status, at the time of surgery the postoperative clinical results of cirrhotic patients are poor. Various factors attributed to cirrhosis rather than cardiac surgery are responsible for the poor prognosis [4] . These factors, such as thrombocytopaenia, compromised immune system and other gastrointestinal disorders are correlated with the severity of cirrhosis [4] . Severity of cirrhosis is mainly classified by the Child-Turcotte-Pugh or Child-Pugh (CP) criteria, based upon the following five clinical factors: (i) presence of encephalopathy, (ii) severity of ascites, (iii) total bilirubin level, (iv) albumin level and (v) prothrombin time [5] . The cirrhotic status is graded into three groups according to the sum of the score (Class A, from 5 to 6; Class B, from 7 to 9; Class C, from 10 to 15). Since these variables are easily acquired with minimally invasive methods in common clinical practice, the CP score has become a widely accepted method for determining liver function and its effects on the postoperative risk status [6, 7] .
As liver cirrhosis is not included in the European and North-American systems for cardiac operative risk evaluation score, its effects on postoperative outcomes are unclear [8, 9] . Consequently, a review by Modi et al. in 2010 showed that several small studies and case reports have studied the effects of liver cirrhosis on the postoperative prognosis. High 30-day mortality and morbidity rates were demonstrated in patients with liver cirrhosis classified by the CP score [2, 4] . Nevertheless, since publication of the aforementioned review, eight studies have been published and thus, an up-to-date systematic review and detailed analysis of the postoperative outcomes, short term (<30 days) and long term (up to 10 years), in these patients are lacking, and recommendations whether to perform cardiac surgery remain unclear.
Hence, the goal of this study was to systematically review observational reports on short-term and overall mortality in patients with liver cirrhosis classified by the CP score undergoing cardiac surgery and to discuss patient-related factors and surgical/technical considerations to improve insight into potential determinants of success.
MATERIALS AND METHODS

Search strategy
A systematic literature search of Medline via PubMed, Embase, CINAHL and the Cochrane Library via Ovid was performed reviewing articles published up to February 2014. A search filter was designed using synonyms for domain (patients with liver cirrhosis undergoing cardiac surgery), determinant (CP classification) and outcome (mortality) ( Table 1) . Firstly, all articles were screened on title and abstract by two independent researchers (Kirolos A. Jacob and Guido Kranenburg). Additionally, a manual search through the references of selected articles and the detected reviews and metaanalyses was performed to pinpoint additional relevant studies. Authors were contacted when a publication could not be obtained or if not all required information could be retrieved from the publication. Consensus was achieved by discussion.
Selection criteria and data extraction
Articles were selected based on predetermined inclusion criteria, being: observational studies reporting on adult (>18 years) human subjects who underwent cardiac surgery in which liver cirrhosis was diagnosed preoperatively by a standardized classification of CP score. Articles had to include the primary outcome, that is, absolute rates of mortality in the postoperative period. Short-term mortality was classified as death within 30 days after cardiac surgery. Overall mortality was mortality occurring within 10 years postoperatively. The latter was divided into subgroups of 1, 5 and 10 years of the follow-up. Secondary outcome included occurrence of major morbidity events within 30 days after surgery. Case series, case reports, expert opinions or guidelines were excluded. Data were extracted from the articles by at least two researchers (Kirolos A. Jacob and Guido Kranenburg), which were year of publication, study design, study population, sample size, type of surgery (coronary artery bypass grafting, valve or combination surgery), short-term and overall mortality rates. If stated, major morbidity event rates and relevant data on independent predictors for poor outcome after cardiac surgery were also included. Predictors that were sought for were the independent variables incorporated in the CP score such as hyperbilirubinaemia and hypoalbuminaemia. When two studies by the same institution reported the same data, the study was considered a duplicate publication, and the publication with either the better quality or more informative data was included.
Statistical analysis
Short-term (<30 days) and overall mortality risks at 1, 5 and 10 years along with major morbidity events within 30 days [(number of events/number of patients) × 100] were calculated for each individual study. Furthermore, pooled and weighted, per study sample size, absolute risks and 95% confidence intervals (CIs) were estimated for the included studies. To compare the increased risk of liver cirrhotic patients with the general cardiac surgical population, and to the general cirrhotic population, the mortality rates of the general cirrhotic population along with mortality rates of the Dutch surgical population at 30 days, 1 and 5 years were set up against the mortality rates of cirrhotic patients undergoing cardiac surgery. Data for mortality rates among the general cirrhotic population and among the Dutch cardiac surgical population were extracted from earlier literature [10] [11] [12] . Also, a standardized mortality ratio (SMR) was calculated in studies, which stated the European System for Cardiac Operative Risk Evaluation (EuroSCORE) of the study population. The SMR was calculated for each study, by dividing the observed number of deaths within 30 days of surgery in the total study sample of liver cirrhotic patients, by the average logistic EuroSCORE (= expected mortality) of the same sample. This analysis was performed only for shortterm mortality. The acquired SMR of each study, along with the averaged weighted SMR of all studies put together, were set up against the SMR of several European countries as the Dutch, English and Swedish cardiac surgical population [12] [13] [14] .
RESULTS
The study selection process is illustrated in Fig. 1 . Overall, 991 articles were identified of which 19 retrospective studies met the inclusion criteria, and were selected for further analysis. An overview of study characteristics, along with, if stated in a study, the predictors of poor outcome obtained by the systematic review is illustrated in Table 2 . These studies included 638 cirrhotic patients, of whom 123 died postoperatively within 30 days, giving an observed weighted short-term mortality after cardiac surgery of 19.3% (95% CI: 16.4-22.5%). When comparing the different CP groups, an 
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observed weighted short-term mortality of 9.0% (95% CI: 6.6-12.2%) was found in Group A, 37.7% (95% CI: 30.8-44.3%) in Group B and 52.0% (95% CI: 33.5-70.0%) in Group C ( Table 3 ). The CP groups in studies were comparable with respect to demographic and surgical characteristics across studies. No data were found in literature on crude mortality within 30 days in the general liver cirrhotic population standardized by the CP score, thus only the general Dutch cardiac surgical population and cirrhotic patients undergoing cardiac surgery were set up against each other. When setting the cardiac surgical crude observed mortality, in cirrhotic patients, within 30 days of the follow-up, against crude observed mortality in Dutch patients without liver cirrhosis undergoing cardiac surgery, it appears that cirrhotic patients have higher deaths rates when compared with the general cardiac surgical population (Fig. 2) . Weighted overall crude mortality in studies with a follow-up within 1 year was high, being 42.0% (95% CI: 36.0-48.3%) in cirrhotic cardiac surgical patients in general. Overall crude mortality subdivided in groups was 27.2% (95% CI: 20.9-34.7%) in Group A, 66.2% (95% CI: 54.3-76.3%) in Group B and 78.9% (95% CI: 56.1-92.1%) in Group C. Also, at 5 and 10 years, the overall mortality increased progressively in all CP classes (Table 4 ). When comparing the crude death rates of cirrhotic patients in general and the Dutch cardiac surgical population with the acquired data on cirrhotic patients undergoing cardiac surgery, at 1 and 5 years of the follow-up, cirrhotic patients had a higher observed crude mortality rates in the years following surgery (Fig. 2) . The high crude mortality within 5 years in cirrhotic patients undergoing surgery was comparable with the general cirrhotic population, but still augmented when compared with the general cardiac surgical population (Fig. 2) .
The SMR in studies (n = 4), which stated the EuroSCORE, is depicted in Fig. 3 . An average SMR of 1.39 (95% CI: 1.08-1.78) for cirrhotic patients was found, compared with 0.40 (95% CI: 0.14-1.17) in the general cardiac surgery population in Netherlands (2013), 0.49 (95% CI: 0.17-1.46) in Sweden (2013) and 0.47 (95% CI: 0.18-1.32) in the UK (2013) (Fig. 3) . Liver cirrhosis, classified by CP score A, B or C, did not increase the SMR significantly when compared with the general cardiac surgical population.
Additionally, an analysis was performed in studies stating shortterm major morbidity in cirrhotic patients after cardiac surgery, for example, reoperation, multiorgan failure, encephalopathy, gastrointestinal (GI) tract complications, >24 h intensive care unit stay and deep wound infections ( (Table 5 ). Noteworthy, reoperation rates were stated by two studies and were for CP class A 12.5-18% and for class B 50-100% [15, 21] (Table 5 ).
DISCUSSION
This systematic review illustrates that the observed weighted short-term mortality is high in patients with liver cirrhosis, especially in CP class B and C when compared with patients without liver cirrhosis undergoing cardiac surgery. Additionally, overall weighted mortality within 1, 5 and 10 years is high in all classes of liver cirrhosis. After adjustment for EuroSCORE, the high mortality compared with the general cardiac surgical population was not statistically significantly increased.
The mean 30-day mortality after cardiac surgery in all patients undergoing surgical procedures in Netherlands is 3.0%, while overall mortality after 1 year is 6.0% [33] . Few and scattered evidence exists on whether to perform cardiac surgery on cirrhotic patients or not. As is previously stated by this systematic review, Overall mortality rates (95% confidence intervals) are given after a weighted calculation to study sample size. LC: liver cirrhosis.
the observed crude mortality percentages within <30 days and for 1, 5 and 10 years tend to be higher in patients with liver cirrhosis compared with the general cardiac surgical population, making liver cirrhosis of great clinical relevance in assessing the perioperative care. When short-term mortality is adjusted for by the EuroSCORE, these increased death rates were still three times as high as the general cardiac surgical population. Yet the new calculated high SMR was insignificant, which implies that not all cirrhotic patients, especially CP class A, may have a higher risk of <30-day mortality. Hence, cirrhosis is to be first classified into CP scores to identify the higher risk patients.
Patients with liver cirrhosis classified by the CP score have a 1-year survival of 100, 81and 45%, in Class A, B and C, respectively (Fig. 2) [10] . Accordingly, it is generally accepted that CP class A patients, unlike classes B and C, may undergo cardiac surgery since the increase of short-term mortality compared with the general cardiac surgical population, is relatively low. Interestingly, this review demonstrates that overall survival in cirrhotic patients after cardiac surgery is poor in all CP classes. Patients with liver cirrhosis class A have an almost seven times higher risk of dying within 12 years after cardiac surgery. Nevertheless, in spite of the high early death rates among patients with liver cirrhosis CP class B and C, case reports have shown that thorough perioperative management of patients can result in good early clinical outcome [34, 35] . Hence, careful and meticulous consideration of perioperative management techniques and surgical strategy, that is, off-pump surgery for isolated coronary artery bypass grafting, is vital and recommended for the safety of cirrhotic patients postoperatively to decrease not only early but also late mortality.
Cirrhosis is classified mainly by the CP score, a subjective score, however readily performed in clinical practice. Another internationally accepted score for the classification of liver cirrhosis is the Model for End-stage Liver Disease (MELD) score. The MELD score has also been shown to predict mortality after cardiac surgery significantly, as it also includes renal function, and has less subjective variables as the CP score, that is, severity of ascites and encephalopathy [25] . Nonetheless, recent studies have shown that CP scores are similar to or even better than MELD scores in predicting mortality after cardiac surgery [6, 7, 36] , though, on the other hand, other studies have shown MELD to be a more superior score to predict outcomes after cardiac surgery [24] . Indeed, in some studies, mortality was better predicted by MELD score than CP score after cardiac surgery [25, 30, 37] .
Hepatic cirrhosis is well known to often be accompanied by anaemia, leucopaenia and thrombocytopaenia due to poor nutritional status, splenomegaly and bleeding from varices [4] . Additionally, impaired coagulation may occur in cirrhotic patients since many of the coagulation factors are synthesized by the liver. The most serious and frequently encountered postoperative complications in cirrhotic patients are infections and excessive mediastinal bleeding ( Table 2 ). Liver dysfunction results in increased infection rates not only by altering the immune status, but also due to the fact that a higher incidence of reoperations takes place in cirrhotic patients as they have multiple bleeding episodes [38] ( Table 2 ). As infections are the leading cause of deaths among hospitalized patients in the postoperative period, scrupulous management of perioperative immune status of patients is crucial in decreasing the rates of infections and diminishing death rates. Hence, meticulous measurements need to be taken to reduce those infections, for example, screening preoperatively for pathogens' carriage, early diagnosis and antibiotics or immune globulin administration are vital. The second major complication following cardiac surgery in cirrhotic patients is, as aforementioned, excessive bleeding, especially from the mediastinum. Thrombocytopaenia and the coexisting coagulopathy lead to increased risk of bleeding and reoperations after cardiac surgery ( Table 2 ). In addition, the cardiopulmonary bypass aggravates these haematological disorders in coagulopathy by hypothermia, haemodilution and hypoperfusion [39] . It has been illustrated that off-pump cardiac surgery in cirrhotic patients results into fewer deaths, especially in patients with severe CP classes, that is, B and C [6, 19, 20] . Though off-pump cardiac surgery is not always possible, its employment as an alternative treatment strategy should be assessed in every patient individually. Noteworthy, despite the good results of off-pump surgery shown by studies analysed in this review, only a small number of patients were included and the overall survival after this technique is unknown [6, 19] . Other treatments that can be performed as preventive measures are vitamin K and tranexamic acid administration along with fresh frozen plasma and packed cell transfusions. 
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Limitations
Selection bias is likely since selection criteria were implemented and because unpublished data, abstracts and presentations were excluded. Also, selection bias within studies could have occurred, nevertheless the detailed observations by the two independent researchers of the demographic and clinical characteristics of included patients, such as age, perioperative procedures and postoperative management protocols within studies, were comparable across the three CP scores. Another drawback of this systematic review is that heterogeneous populations from various countries, with different kinds of surgical procedures, were found across studies that were used for this mortality analysis. Moreover, the number of studies included was retrospective and incorporated small sample sizes, studying a subjective score as the CP score. Nonetheless, the retrieved results were considered to be the best available evidence. Additionally, pooling data illustrated a strong relationship between liver cirrhosis and mortality after cardiac surgery across all CP classes, which illustrate that differences between populations in this situation are not significantly present. Overall mortality rates (95% confidence intervals) are given after a weighted calculation to study sample size. LC: liver cirrhosis. Overall morbidity rates (95% confidence intervals) are given after a weighted calculation to study sample size. LC: liver cirrhosis.
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